Search | IOVS | ARVO Journals

Showing 1 – 20 of 24

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Positive QuantiFERON-TB Gold Test in Uveitis Patients as part of a screening – Results from the last 10 years from tertiary care in a non-endemic area

Lynn Sophie zur Bonsen; Antonia Koch; Anne Rübsam; Uwe Pleyer; Sebastian Albus; Dominika Pohlmann

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5063.

ARVO Annual Meeting Abstract June 2023

A phase 1 trial treating autoimmune uveitis with a novel intraocular small molecule - further data analysis

Stephan R Thurau; Christoph M E Deuter; Arnd Heiligenhaus; Uwe Pleyer; Joachim Van Calster; Talin Barisani-Asenbauer; Stefan Sperl; Romana Seda-Zehetner; Franz Obermayr; Gerhild Wildner

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3544.

ARVO Annual Meeting Abstract June 2020

OCT-based automated vitreous inflammation score: a promising biomarker in dexamethasone implant treated uveitis patients

Dominika Pohlmann; Jan Henrik Terheyden; Moritz Berger; Giovanni Ometto; Giovanni Montesano; Felicitas Neuber; Maximilian W.M. Wintergerst; Tariq Aslam; Xiaoxuan Liu; Frank G Holz; Pearse Andrew Keane; David P. Crabb; Alastair K Denniston; Robert Finger; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3245.

ARVO Annual Meeting Abstract June 2020

OCT-assessed vitreous inflammation in uveitis patients treated with intravitreal dexamethasone implants

Jan Henrik Terheyden; Moritz Berger; Giovanni Ometto; Dominika Pohlmann; Giovanni Montesano; Magdalena Langner; Maximilian W.M. Wintergerst; Tariq Aslam; Xiaoxuan Liu; Frank G. Holz; Pearse Andrew Keane; David Paul Crabb; Uwe Pleyer; Alastair K Denniston; Robert Patrick Finger

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3246.

ARVO Annual Meeting Abstract July 2019

Analysis of peripheral inflammatory T-cell subsets and their effector functions in patients with Birdshot Retinochoroiditis

Dominika Pohlmann; Janine Trombke; Lucie Loyal; Julian Braun; Uwe Pleyer; Andreas Thiel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):809.

ARVO Annual Meeting Abstract July 2019

Biomorphological findings in CMV-associated anterior uveitis

Uwe Pleyer; Therese Walla; Matthias Lenglinger

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6684.

ARVO Annual Meeting Abstract July 2018

Immunosuppressants and/or Anti-Vascular Endothelial Growth Factor inhibitors in Punctate Inner Choroidopathy? Follow-up Results with Optical Coherence Tomography Angiography

Dominika Pohlmann; Uwe Pleyer; Antonia M Joussen; Sibylle Winterhalter

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):423.

ARVO Annual Meeting Abstract July 2018

Comparison of DMEK and DSAEK in high and low risk posterior lamellar keratoplasty.

Jesper Hjortdal; Uwe Pleyer; Conor C Murphy; Derek Tole; Bertrand Vabres

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1299.

ARVO Annual Meeting Abstract September 2016

Mycophenolate sodium significantly reduces the relapse rate in patients with non-infectious intermediate uveitis

Christoph M E Deuter; Katrin Engelmann; Arnd Heiligenhaus; Ines Lanzl; Friederike Mackensen; Thomas Ness; Uwe Pleyer; Nicole Stuebiger; Manfred Zierhut; Deshka Doycheva

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12)

Anatomy and Pathology/Oncology May 2016

Upregulation of Transient Receptor Potential Vanilloid Type-1 Channel Activity and Ca 2+ Influx Dysfunction in Human Pterygial Cells

PDF

Fabian Garreis; Antje Schröder; Peter S. Reinach; Stefanie Zoll; Noushafarin Khajavi; Priyavathi Dhandapani; Alexander Lucius; Uwe Pleyer; Friedrich Paulsen; Stefan Mergler
TAGS: pterygium, up-regulation (physiology), pathophysiology, vascular endothelial growth factor a, reverse transcriptase polymerase chain reaction
Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2564-2577. https://doi.org/10.1167/iovs.16-19170

ARVO Annual Meeting Abstract June 2015

The intraocular cytokinome is linked to clinical characteristics in human toxoplasmosis

Claudia Thieme; Stephan Schlickeiser; Claudia Dames; Sylvia Metzner; Hans-Dieter Volk; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1893.

ARVO Annual Meeting Abstract April 2014

Rituximab for treatment refractory ocular cicatricial pemphigoid (OCP)

Anne Ruebsam; Richard Stefaniak; Margitta Worm; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1494.

ARVO Annual Meeting Abstract April 2014

Functional expression of thermo-sensitive transient receptor potential channels in cultivated human corneal endothelial cells (HCEC-12)

Charlotte Nora Mertens; Stefan Mergler; Ersal Türker; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):2050.

ARVO Annual Meeting Abstract April 2014

Aganirsen antisense oligonucleotide eye drops inhibit corneal neovascularization and reduce need for transplantation: the I-CAN study

Claus Cursiefen; Eric Viaud; Felix Bock; Francois Majo; Beatrice E Frueh; Gerd Geerling; Uwe Pleyer; Bjoern O Bachmann; Thomas Reinhard; Berthold Seitz

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):5050.

ARVO Annual Meeting Abstract April 2014

Management of primary intraocular lymphoma (PIOL): results from the prospective German PIOL Registry (PIOL-R)

Uwe Pleyer; Agnieszka Korfel; Martina Herwig; Rainer Guthoff; Matthias Lüke; Tobias Meyer-ter-Vehn; Antonia M Joussen; Michael Böhm; Friederike Mackensen; Kristoph Jahnke; BMBF

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):88.

ARVO Annual Meeting Abstract June 2013

Atypical findings in Spectral Domain Optical Coherence Tomography of Ocular Toxoplasmosis with Active Lesions

Florian Heussen; Yanling Ouyang; Qing Shao; Antonia Joussen; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5923.

ARVO Annual Meeting Abstract June 2013

IV Secukinumab Is An Effective Treatment In Patients With Noninfectious Uveitis Requiring Steroid Sparing Immunosuppressive Therapy

Erik Letko; Steven Yeh; Cynthia Grosskreutz; Uwe Pleyer; C. Stephen Foster; Mitchell Brigell

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):5929.

ARVO Annual Meeting Abstract March 2012

Transient Receptor Potential Melastatin 8 (TRPM8) Channels Mediate Complex Calcium Responses in Human Corneal Endothelial Cells

Stefan Mergler; Monika Valtink; Monika Sahlmüller; Peter S. Reinach; Katrin Engelmann; Uwe Pleyer

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6015.

ARVO Annual Meeting Abstract March 2012

Ozurdex: A new therapeutic option in uveitis - Clinical outcome from two German uveitis centers

Uwe Pleyer; Matthias Klamann; Sibylle Winterhalter; Stephan R. Thurau

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2249.

ARVO Annual Meeting Abstract April 2011

Dry-eye Symptoms In Patients After Eyelid Reconstruction With Full-thickness Eyelid Defects

Johannes Gonnermann; Julian P. Klein; Matthias K. Klamann; Anna-Karina Maier; Uwe Pleyer; Antonia M. Joussen; Eckart Bertelmann

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3808.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Positive QuantiFERON-TB Gold Test in Uveitis Patients as part of a screening – Results from the last 10 years from tertiary care in a non-endemic area

A phase 1 trial treating autoimmune uveitis with a novel intraocular small molecule - further data analysis

OCT-based automated vitreous inflammation score: a promising biomarker in dexamethasone implant treated uveitis patients

OCT-assessed vitreous inflammation in uveitis patients treated with intravitreal dexamethasone implants

Analysis of peripheral inflammatory T-cell subsets and their effector functions in patients with Birdshot Retinochoroiditis

Biomorphological findings in CMV-associated anterior uveitis

Immunosuppressants and/or Anti-Vascular Endothelial Growth Factor inhibitors in Punctate Inner Choroidopathy? Follow-up Results with Optical Coherence Tomography Angiography

Comparison of DMEK and DSAEK in high and low risk posterior lamellar keratoplasty.

Mycophenolate sodium significantly reduces the relapse rate in patients with non-infectious intermediate uveitis

Upregulation of Transient Receptor Potential Vanilloid Type-1 Channel Activity and Ca 2+ Influx Dysfunction in Human Pterygial Cells

The intraocular cytokinome is linked to clinical characteristics in human toxoplasmosis

Rituximab for treatment refractory ocular cicatricial pemphigoid (OCP)

Functional expression of thermo-sensitive transient receptor potential channels in cultivated human corneal endothelial cells (HCEC-12)

Aganirsen antisense oligonucleotide eye drops inhibit corneal neovascularization and reduce need for transplantation: the I-CAN study

Management of primary intraocular lymphoma (PIOL): results from the prospective German PIOL Registry (PIOL-R)

Atypical findings in Spectral Domain Optical Coherence Tomography of Ocular Toxoplasmosis with Active Lesions

IV Secukinumab Is An Effective Treatment In Patients With Noninfectious Uveitis Requiring Steroid Sparing Immunosuppressive Therapy

Transient Receptor Potential Melastatin 8 (TRPM8) Channels Mediate Complex Calcium Responses in Human Corneal Endothelial Cells

Ozurdex: A new therapeutic option in uveitis - Clinical outcome from two German uveitis centers

Dry-eye Symptoms In Patients After Eyelid Reconstruction With Full-thickness Eyelid Defects

To View More...

You must be signed into an individual account to use this feature.